{"name":"Merida Biosciences","slug":"merida-biosciences","ticker":"","exchange":"","domain":"merida.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxOQkxmbk12TjRSRXhEVnFZTGotcy1sUlZsYXdPSTNBeV9BTk40QnJraDBzeHppNGpuR0JLVmk3TV82a0drdXhTdUpGOTgzMk5DbVdlclZYMTQzSzlfelE1eTdwYXpGVXBNMzV6eW05ZjBPLTFTMHF5TUNscEVlTkhqWQ?oc=5","date":"2025-12-19","type":"pipeline","source":"Fierce Biotech","summary":"Fierce Biotech Fundraising Tracker '25: Atavistik adds $120M; Syneron Bio secures new funds - Fierce Biotech","headline":"Fierce Biotech Fundraising Tracker '25: Atavistik adds $120M; Syneron Bio secures new funds","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxONlJzZ3FhOGtabXhHUHpvXy1wVWdDa3RWWGtBb1QtcHNvMHZ2ODRWRTZEX3NpTnAtU3kwbVVGQUFYWTdtUUlJUWczS2F6dWtTNDVBSVhkdlFfWm1uVklkQ3JVWVpjSEhPN3htSWdpeVptX1VOU1VYUFB0YUVHZTNkazluaWFhY3lr?oc=5","date":"2025-04-18","type":"pipeline","source":"pharmaphorum","summary":"Merida raises $121m for Graves drug, and other financings - pharmaphorum","headline":"Merida raises $121m for Graves drug, and other financings","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxPcTBiYUJiQ0ZVdjVDRW41VW9wc3dJQ3RtT00yLTZTNGJ5Q2RaeVZjNW80Tm9wMkFGUU9IcnpBUGQ2NUhLSi1sVWdtR3VnSV9SamJ5dW92dmVINlUwRkJnbGN3WnF4eTB1LXBjR3J3UXY5T3Z5dGNlZ0VJdTZKVFpLamVQZmtVMXdlV2JCMERqRlFiU3RYRl9FY3g3N2hxQnVPMnEwaUFldXl3VjQzdXVkSC1NTWRLVG5hcnFyNkJEM21qa0tDMGxNdG55QXp1eVlIdWRDUC1CSVNDc2JDaW1ndw?oc=5","date":"2025-04-10","type":"pipeline","source":"Pharmaceutical Executive","summary":"Merida Biosciences Launches with $121 Million in Series A Financing to Develop Precision Therapeutics for Autoimmune, Allergic Diseases - Pharmaceutical Executive","headline":"Merida Biosciences Launches with $121 Million in Series A Financing to Develop Precision Therapeutics for Autoimmune, Al","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxPdzVLYmtKZWlRbHlCeG1qV2hJR1JadncwWVNWSDRRdmxkd0JEVjA0SmMtRF9OV2lOX3ozSEVsamJyWS1wYW9WTEdMc3padG5CUF9jS0lpcEVOVXZsYlZrQll3aHd3Y1BfU3hIV1Y4UkpmLXZIV2RLMTlOQXhXejRaNzMwMl9Id05HV3VFMXcyODdfNGFWd2I4YUsyZm13MW83Y01mV1ZQY1I?oc=5","date":"2025-04-09","type":"pipeline","source":"Pharmaceutical Technology","summary":"Merida launches with $121m to target autoimmune antibodies - Pharmaceutical Technology","headline":"Merida launches with $121m to target autoimmune antibodies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxQNEg3Sm9uQnUxaWxSdjZQSTRITWY2WVFtYWZ3cnBUUDdRYThTenlLcWVZOTVYa3UzbkJLUHhkS0ZROWhQU0R2VFRlWERTRkc2N0szdUJmSXdlSlRrOGZ2Qk4wMGJKNDJEOVlFTHk0OUdUNENydmp2eVQ4cU03OVZHRldySGJhMl9IMUNRblIzQXUyRzJpemtN?oc=5","date":"2025-04-09","type":"pipeline","source":"Contract Pharma","summary":"Merida Biosciences Launches with $121M Series A - Contract Pharma","headline":"Merida Biosciences Launches with $121M Series A","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE5xQktsNGJqZmlFNjVxckgyUU92a3pocDRVVnBCSnJ0Q2hoMVRqVEZZOTFGbGRlY1paUGh6WXZnRVp2OXVDRl9hem5wbHpua3ZQeDBabFRjbkN5QlNPNVRR?oc=5","date":"2025-04-09","type":"pipeline","source":"The Pharma Letter","summary":"Merida Biosciences - The Pharma Letter","headline":"Merida Biosciences","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-gFBVV95cUxNcTZpeVlKSTcxTW5fVlc5Y1ZFUXBEcVVaYTc0WTFleWJUMmdvWFlxNDFUMVk1djBEaFZpNG9sblJzR2UzVnAzTlgydGg3NW9vZlNFZmN3LTBicWdhQVpJTGZKMWpCeGlfNlVWdVlZX3pBc21NUW84S2NYSGQtV3RRUDY5RDdzdGJGVHR2X3F2dVFQZVpwTFRmUjZoOGhhMDJrWmhmelFwdWpJczNkNGgyWDBTVlktMnEwZlhyY2toOE53cmdubGRlOF84SUxpbEtEUGhrcm8xS1dPV3BPTlBIdGJ0UzNuVFM3N3JBTDNoUE9mQlRQTHl5a0dn?oc=5","date":"2025-04-08","type":"pipeline","source":"businesswire.com","summary":"Merida Biosciences Launches with $121M to Create Therapeutics for Multiple Autoimmune and Allergic Diseases - businesswire.com","headline":"Merida Biosciences Launches with $121M to Create Therapeutics for Multiple Autoimmune and Allergic Diseases","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE1NaHdYclg3ekVVaUpHNDdPbDF4OXVpSDZsY0dBN1FWblVSWE5Bcjg3LXRsM0VzaDlVTDAwM3lIMG9hWU5oZ3NmaHNIbW5kMzUtenhN?oc=5","date":"2025-04-08","type":"pipeline","source":"FirstWord Pharma","summary":"Merida bags $121M to home in on disease-causing antibodies - FirstWord Pharma","headline":"Merida bags $121M to home in on disease-causing antibodies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxPTV9zUVljQTEtbl9iaWtndmpfb0lHVjltX1c4UlZIcUZKZElKZ2ZMTU1MNkhHUURmMEpzRElTUEl2cmhzaGtRTk9SLWxvRjBRa3VtRnQwcGQyUkk4elBBaUJMRVEyc180bWxaTi1DTjhPTHdJUWFCQmpHYkduZWVabzAtY0wteFFVVGF2UjdmM2praGJSMHY2S1NjVVJ4SnU3X2o1S0w3dGlRekRFYjd6WTdVMC12WHk2X3c?oc=5","date":"2025-04-08","type":"trial","source":"Endpoints News","summary":"Exclusive: Merida Biosciences gets $121M to treat autoimmune and allergy diseases at their roots - Endpoints News","headline":"Exclusive: Merida Biosciences gets $121M to treat autoimmune and allergy diseases at their roots","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxPVVFFVWpYYXliMlVGRThEVGZnM2pVRmFCbUdIamJfM0pEZDlOTm1IeXBFcHNON0s2clFXUExKVEJYSjZGNTN6TmVucERhVE9aazUxdFlKaXRMVGYzOGlBUzhhRm8yTmpDRTdHNlNtU0M3R3dBcDlkVWw2QTFtZUo2NUJYRGFlYmg1Q282eXdBcThsc29tMG4yRHNCUENSVlBhNDNacEVrczk4Slh0?oc=5","date":"2025-04-08","type":"pipeline","source":"Fierce Biotech","summary":"Third Rock-backed Merida launches with $121M series A to fund autoimmune pipeline - Fierce Biotech","headline":"Third Rock-backed Merida launches with $121M series A to fund autoimmune pipeline","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}